glp 1 and strength training Physical Therapy & — Progressive Physical Therapy How to Work Out When

Similarly, another meta-analysis of 5 cardiovascular outcome trials reported no significant effect of GLP-1RAs treatment on ventricular fibrillation in T2DM patients [13]

Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have recently received Food and Drug Administration (FDA) approval for obesity management

While nausea, vomiting, and diarrhea are the most commonly reported gastrointestinal adverse effects with GLP-1-based therapies (occurring in 15-40% of patients depending on the agent and dose), FDA prescribing information for several of these medications does list dyspepsia (indigestion) and, in some cases, gastroesophageal reflux disease (GERD) as reported adverse reactions

References National Center for Biotechnology Information

PubMed CrossRef Arans C, Edvardsson CE, Shevchouk OT, et al